Healthcare | July 05, 2022
Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries
Medicines, including insulin, to be available in 40 lower-income countries
Medicines, including insulin, to be available in 40 lower-income countries
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Strengthens investment in channels of the future to expand patient reach
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
Subscribe To Our Newsletter & Stay Updated
